Lista de obras - Christine C Roberts - Dominio Público Uruguay

A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions

article

Assay Challenges for Emerging Infectious Diseases: The Zika Experience

scholarly article by Christine C Roberts et al published 2 October 2018 in Vaccines

Comparison of HPV genotypes and viral load between different sites of genital tract: the significance for cervical cancer screening

artículo científico publicado en 2014

Comparison of real-time multiplex human papillomavirus (HPV) PCR assays with INNO-LiPA HPV genotyping extra assay

artículo científico publicado en 2010

Comparison of real-time multiplex human papillomavirus (HPV) PCR assays with the linear array HPV genotyping PCR assay and influence of DNA extraction method on HPV detection

artículo científico publicado en 2011

Concordance assessment between a multiplexed competitive Luminex immunoassay, a multiplexed IgG Luminex immunoassay, and a pseudovirion-based neutralization assay for detection of human papillomaviruse types 16 and 18.

artículo científico publicado en 2014

Detection of HPV in Norwegian cervical biopsy specimens with type-specific PCR and reverse line blot assays.

artículo científico publicado en 2006

Development of a human papillomavirus competitive luminex immunoassay for 9 HPV types

artículo científico publicado en 2014

Emerging infectious disease laboratory and diagnostic preparedness to accelerate vaccine development

scientific article published on 16 July 2019

Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection

artículo científico publicado en 2009

Evaluation of the HPV 18 antibody response in Gardasil® vaccinees after 48 mo using a pseudovirion neutralization assay

artículo científico publicado en 2012

Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial

artículo científico publicado en 2017

Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial

artículo científico publicado en 2010

HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine

artículo científico publicado en 2008

Immunogenicity and safety of an investigational tetravalent recombinant subunit vaccine for dengue: results of a Phase I randomized clinical trial in flavivirus-Naïve adults

artículo científico publicado en 2019

Impact of baseline covariates on the immunogenicity of the 9-valent HPV vaccine - A combined analysis of five phase III clinical trials

artículo científico

Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women

artículo científico publicado en 2010

Importance of specimen type in detecting human papillomavirus DNA from the female genital tract

artículo científico publicado en 2009

Incidence and predictors of human papillomavirus-6, -11, -16, and -18 infection in young norwegian women

scientific article published on July 2011

Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine - Preliminary Report.

artículo científico publicado en 2017

The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years

artículo científico

The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years

artículo científico

ZIKA-001: Safety and Immunogenicity of an Engineered DNA Vaccine Against ZIKA virus infection

artículo científico publicado en 2017

Zika-Induced Male Infertility in Mice Is Potentially Reversible and Preventable by Deoxyribonucleic Acid Immunization

article

Lista de obras de Christine C Roberts

A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions

Assay Challenges for Emerging Infectious Diseases: The Zika Experience

Comparison of HPV genotypes and viral load between different sites of genital tract: the significance for cervical cancer screening

Comparison of real-time multiplex human papillomavirus (HPV) PCR assays with INNO-LiPA HPV genotyping extra assay

Comparison of real-time multiplex human papillomavirus (HPV) PCR assays with the linear array HPV genotyping PCR assay and influence of DNA extraction method on HPV detection

Concordance assessment between a multiplexed competitive Luminex immunoassay, a multiplexed IgG Luminex immunoassay, and a pseudovirion-based neutralization assay for detection of human papillomaviruse types 16 and 18.

Detection of HPV in Norwegian cervical biopsy specimens with type-specific PCR and reverse line blot assays.

Development of a human papillomavirus competitive luminex immunoassay for 9 HPV types

Emerging infectious disease laboratory and diagnostic preparedness to accelerate vaccine development

Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection

Evaluation of the HPV 18 antibody response in Gardasil® vaccinees after 48 mo using a pseudovirion neutralization assay

Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial

Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial

HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine

Immunogenicity and safety of an investigational tetravalent recombinant subunit vaccine for dengue: results of a Phase I randomized clinical trial in flavivirus-Naïve adults

Impact of baseline covariates on the immunogenicity of the 9-valent HPV vaccine - A combined analysis of five phase III clinical trials

Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women

Importance of specimen type in detecting human papillomavirus DNA from the female genital tract

Incidence and predictors of human papillomavirus-6, -11, -16, and -18 infection in young norwegian women

Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine - Preliminary Report.

The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years

The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years

ZIKA-001: Safety and Immunogenicity of an Engineered DNA Vaccine Against ZIKA virus infection

Zika-Induced Male Infertility in Mice Is Potentially Reversible and Preventable by Deoxyribonucleic Acid Immunization